Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2012 | 03-2011 | 03-2010 | 03-2009 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,495 | -11,755 | -19,024 | -31,597 | -40,930 |
| Depreciation Amortization | 4,336 | 3,948 | 4,898 | 5,016 | 6,124 |
| Income taxes - deferred | 789 | 970 | 954 | 721 | 527 |
| Accounts receivable | -5,284 | -1,923 | 2,210 | -2,539 | -2,797 |
| Accounts payable and accrued liabilities | 287 | 2,480 | -1,387 | -2,402 | 3,237 |
| Other Working Capital | -11,745 | 497 | 3,564 | -3,523 | -8,025 |
| Other Operating Activity | 13,756 | 7,357 | 1,423 | 16,019 | 12,990 |
| Operating Cash Flow | $3,634 | $1,574 | $-7,362 | $-18,305 | $-28,874 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,752 | -1,004 | 5,979 | -23,367 | -31,936 |
| PPE Investments | -1,745 | -1,804 | -1,800 | -3,751 | -3,760 |
| Net Acquisitions | N/A | N/A | -1,750 | N/A | N/A |
| Sale Of Investment | 1,017 | 0 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -69 |
| Other Investing Activity | 0 | 456 | 6,389 | 313 | -5,209 |
| Investing Cash Flow | $-17,480 | $-2,352 | $8,818 | $-26,805 | $-40,905 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,680 | 1,374 | 979 | 46,941 | 3,938 |
| Common Stock Repurchased | 0 | 0 | N/A | -711 | -1,868 |
| Financing Cash Flow | $14,680 | $1,374 | $979 | $46,230 | $2,070 |
| Exchange Rate Effect | -675 | 447 | 568 | -1,377 | 105 |
| Beginning Cash Position | 5,831 | 4,788 | 1,785 | 2,042 | 69,646 |
| End Cash Position | 5,990 | 5,831 | 4,788 | 1,785 | 2,042 |
| Net Cash Flow | $159 | $1,043 | $3,003 | $-257 | $-67,604 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,634 | 1,574 | -7,362 | -18,305 | -28,874 |
| Capital Expenditure | -1,745 | -1,804 | -1,800 | -3,751 | -3,760 |
| Free Cash Flow | 1,889 | -230 | -9,162 | -22,056 | -32,634 |